Department of Cardiac Surgery, Bichat Hospital, France.
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):111-4. doi: 10.1177/2048872612449417.
We report and examine the outcomes of emergency venoarterial extracorporeal membrane oxygenation (ECMO) support initiated via percutaneous cannulation of the femoral vessels.
Fifteen patients undergoing percutaneous venoarterial ECMO under emergency circumstances between January 2009 and July 2011 were identified. The implantation technique employed the Seldinger's technique for both arterial and venous cannulae. Whenever possible antegrade perfusion of the ipsilateral lower limb was performed through percutaneous catheterization of the superficial femoral artery (SFA).
ECMO support was indicated mainly for cardiac arrest (n=9, 60%) or cardiogenic shock (n=4, 27%), while two (13%) patients required ECMO support for acute respiratory failure. In five (33%) patients, ECMO was implanted during cardiopulmonary resuscitation manoeuvres. ECMO support was maintained for a mean of 4.9 days. Eight patients (53%) were successfully weaned from the device. Thirty-day mortality was 53%. Seven patients (47%) suffered early complications, namely two wound infections, one thrombosis of the venous cannula, one erroneous implantation of the arterial cannula into the femoral vein, one local dissection of the femoral artery, one retroperitoneal bleeding and one acute limb ischaemia. No long-term vascular complications were noted.
Percutaneous femoral cannulation for ECMO support remains a prompt approach for establishing extracorporeal circulatory support in acute cardiopulmonary failure when conditions for performing femoral vessel cut down are not optimal. However, vascular complications are frequent and carry a significant morbidity and mortality.
我们报告并检查了通过股血管经皮插管紧急启动的静脉动脉体外膜肺氧合(ECMO)支持的结果。
2009 年 1 月至 2011 年 7 月期间,确定了 15 名在紧急情况下接受经皮静脉动脉 ECMO 的患者。采用 Seldinger 技术对动静脉插管进行植入。在可能的情况下,通过经皮穿刺股浅动脉(SFA)对同侧下肢进行逆行灌注。
ECMO 支持主要用于心脏骤停(n=9,60%)或心源性休克(n=4,27%),而两名(13%)患者需要 ECMO 支持治疗急性呼吸衰竭。在五名(33%)患者中,在心肺复苏操作期间植入 ECMO。ECMO 支持平均维持了 4.9 天。8 名患者(53%)成功脱机。30 天死亡率为 53%。7 名患者(47%)发生早期并发症,包括 2 例伤口感染、1 例静脉插管血栓形成、1 例动脉插管错误植入股静脉、1 例股动脉局部夹层、1 例腹膜后出血和 1 例急性肢体缺血。未观察到长期血管并发症。
在股血管切开条件不理想时,经皮股血管插管进行 ECMO 支持仍然是急性心肺衰竭时建立体外循环支持的快速方法。然而,血管并发症频繁,且具有显著的发病率和死亡率。